Gastroesophageal reflux in the French general population: National survey of 8000 adults;Le reflux gastro-œsophagien dans la population générale française: Résultats d'une enquête sur 8000 sujets adultes

Presse Medicale

Volumn 35, Issue 1 I, 2006, Pages 23-31

  Bretagne, Jean François ^a   Richard Molard, Bruno ^b   Honnorat, Charles ^c   Caekaert, Agnès ^d   Barthélemy, Philippe ^d  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Service de kinésithérapie   (France)

^c Faculté de Médecine   (France)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTACID AGENT; PROTON PUMP INHIBITOR; PROTON PUMP;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONSULTATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRANCE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT SATISFACTION; POPULATION; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; QUANTITATIVE ANALYSIS; RISK FACTOR; SEX; SMOKING; TOBACCO; ADOLESCENT; AGE; AGED; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG ANTAGONISM; DRUG COMBINATION; ENDOSCOPY; MIDDLE AGED; QUESTIONNAIRE; SELF MEDICATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALGINATES; ANTACIDS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; ENDOSCOPY; FEMALE; FRANCE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PRACTICE GUIDELINES; PROTON PUMPS; QUESTIONNAIRES; RISK FACTORS; SELF MEDICATION;

EID: 33644867334     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74515-8     Document Type: Article

References (40)

1. Conférence de Consensus. Reflux gastro-œsophagien de l'adulte: diagnostic et traitement. Gastroenterol Clin Biol. 1999; 23: 56-65.
2. Brown DM, Everhart JE. Cost of digestive disease in the United States. In: Everhart JE ed. Digestive Disease in the United States: epidemiology and impact. US Government Printing Office, Washington, DC: NIH Publication. 1994. 94-1447: 55.
3. Schwenkglenks M, Marbet UA, Szucs TD. Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study. Soz Präventivmed. 2004; 49: 51-61.
4. Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol. 1999; 231 (suppl): 3-8.
5. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR, Rodriguez-Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol. Ther 2004; 19: 95-105.
6. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted county, Minnesota. Gastroenterology. 1997; 112: 1448-56.
7. Locke GR, Talley NJ, Fett SL, Zinmeister AR, Melton LJ. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999; 106: 642-9.
8. Louis E, DeLooze D, Deprez P, Hiele M, Urbain D, Pelckmans P et al. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol. 2002; 14: 279-84.
9. Bruley des Varannes S, Galmiche JP, Bernades P, Bader JP. Douleurs épigastriques et régurgitations: épidémiologie descriptive dans un échantillon représentatif de la population française adulte. Gastroenterol Clin Biol. 1988; 12: 721-8.
10. Vallot T, Bruley des Varannes S, Grimaud JC, Ruszniewski P, Richard A, Gentin F et al. Épidémiologie du reflux gastro-œsophagien en médecine générale. Gastroenterol Clin Biol. 1999; 23: 1139-44.
11. Colin R, Bruley des Varannes S, Humeau B, Lacau Saint Guily L, Blais J, Reyes P et al. Epidémiologie du reflux gastro-œsophagien typique de l'adulte : résultats d'une étude prospective nationale en médecine générale. Gastroenterol Clin Biol. 2002; 26: A109.
12. Ardilly P. Les techniques des sondages. Editions Technip: Paris; 1994; p. 154-64.
13. Deville JC, Särndal CE, Sautory O. Generalized raking procedures in survey sampling. J Am Statist Assoc. 1993; 88: 1013-20.
14. Institut national des statistiques et des études économiques (Insee). Enquête sur l'emploi, mars 2002. Résultats "Société", no 5, août 2002.
15. Garrow JS, Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes. 1985; 9: 147-53.
16. Joint FAO/WHO/UNU Expert Consultation. Energy and protein requirements. WHO Technical Report Series. Organisation Mondiale de la Santé, Genève 1985; 724, 1-67.
17. Bommelaer G. Reflux gastro-œsophagien de l'adulte. Définition, épidémiologie, histoire naturelle. Gastroenterol Clin Biol. 1999; 23 (suppl): 3-9.
18. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990; 335: 205-8.
19. Klinkenberg-Knol E, Castell DO. Clinical spectrum and diagnosis of gastroesophageal reflux disease. In: Castell DO ed. The Esophagus. Boston: Little & Brown; 1993. p. 441-8.
20. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med. 1995; 27: 67-70.
21. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity, and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J. 2000; 113: 178-81.
22. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther. 2000; 14: 158-94.
23. Wong WM, Lai KC, Lam KF, Hui WM, Tu WH, Lam CL et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther. 2003; 18: 595-604.
24. Wang JH, Luo JY, Dong L, Gong J, Tong M. Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China. World J Gastroenterol. 2004; 10: 1647-51.
25. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/ International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol. 1999; 34 (suppl 231): 20-8.
26. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976; 21: 953-6.
27. Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol. 1991; 26: 73-81.
28. Jones RH, Lydeard SE, Hobbs FD, Kenkre JE, Williams EI, Jones SJ et al. Dyspepsia in England and Scotland. Gut. 1990; 31: 401-5.
29. Shaheen N, Provenzale D. The epidemiology of gastroesophageal reflux disease. Am J Med Sci. 2003; 326: 264-73.
30. Lin M, Gerson LB, Lascar R, Davila M, Triadafilopoulos G. Features of gastroesophageal reflux disease in women. Am J Gastroenterol. 2004; 99: 1442-7.
31. ObEpi 2003 : L'obésité et le surpoids en France. http://www.tns-sofres.com/etudes/sante.
32. Murray L, Johnston B, Lane A, Harvey I, Donovan J, Nair P et al. Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemiol. 2003; 32: 645-50.
33. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003; 290: 66-72.
34. Lundell L, Ruth M, Sandberg N, Bove-Nielsen M. Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sci. 1995; 40: 1632-5.
35. Lagergren J, Bergstrom R, Nyren O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut. 2000; 47: 26-9.
36. Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol. 1999; 34 (suppl 231): 29-37.
37. Johnston BT, Gunning J, Lewis SA. Health care seeking by heartburn sufferers is associated with psychosocial factors. Am J Gastroenterol. 1996; 91: 2500-4.
38. Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists. Am J Gastroenterol. 2001; 96: 673-6.
39. Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol. 1989; 156: 7-13.
40. Dent J, Brun J, Fendrick AM, Fennerty MB, Jenssens J, Kahrilas PJ et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut. 1999; 44 (suppl 2): 1-16.